MLSS

Milestone Scientific Inc. Common Stock (MLSS)

Stock · AMEX · Health Care

$0.33as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 30, 2026

MLSS Highlights Scalable Growth Platform for CompuFlo®. Milestone Scientific said it is building a scalable growth platform for its CompuFlo® medical business. The company aims to expand the product line and increase market reach. This announcement may support future revenue growth. The stock is trading near its 52‑week low but has support at $0.40.

Active signals

Resistance level
$0.398932
Industry
Industrial Specialties

What MLSS's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike49-2.9%45%
Bollinger Band Breakdown21+6.1%62%
Bollinger Band Breakout22-0.9%45%
200-Day Moving Average TouchActive now17+2.1%53%
Any 20-session window (baseline)-3.3%41%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About MLSS

Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for dental procedures that require local anesthetic…

Sector
Health Care
Industry
Industrial Specialties
Employees
15

Fundamentals

1-day range
$0.3205$0.3429
Market cap
$41.13M
P/E (trailing)
—
P/E (forward)
-9.33
EPS (trailing)
$-0.05
Dividend yield
—
Beta
1.19
Avg. volume
124.6K
52-week range
$0.2181$0.5796
Next earnings: August 13, 2026 · EPS estimate $-0.01confirmed

How Milestone Scientific Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$8.97MSG&A$11.58M (129%)Cost of Revenue$2.57M (29%)R&D$449.5K (5%)MLSS

Source: 10-K filed Mar 31, 2026 · via SEC EDGAR / Finnhub

Gross Profit$6.41M(71%)
Operating Income-$5.70M(-64%)

Forecasts

2 analyst ratings

Buy 88%
Hold 13%
Sell 0%
1-year price forecast
High
$1.5
+354.5%
Median
$1.25
+278.8%
Low
$1
+203.0%

Milestone Scientific Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • MLSS
    Milestone Scientific Inc. Common Stock
    $0.33
    ▲ 0.00%
    Market cap $41.13MP/E —
    $0.2181$0.5796
  • ADSEW
    ADS-TEC ENERGY PLC Warrant
    $0.21
    ▼ 4.33%
    Market cap $38.90MP/E —
    $0.14$1.37
  • MAMO
    Massimo Group Common Stock
    $0.926
    ▼ 0.43%
    Market cap $44.56MP/E 9.77
    $0.66$5.59
  • NTRB
    Nutriband Inc. Common Stock
    $6.22
    ▼ 0.80%
    Market cap $35.43MP/E —
    $2.8$9.19
  • MYO
    Myomo Inc. Common Stock
    $1.2
    ▼ 7.69%
    Market cap $50.62MP/E —
    $0.605$1.89
  • COCH
    Envoy Medical Inc. Class A Common Stock
    $0.668
    ▲ 3.57%
    Market cap $52.34MP/E —
    $0.3625$0.9634
  • APT
    Alpha Pro Tech Ltd. Common Stock
    $5.55
    ▼ 2.97%
    Market cap $53.33MP/E 14.66
    $4.34$7.5

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Institutional Ownership

March 31, 2026

Total shares held
4.19M
Total value held
$1.20M
Institutional holders
29
Top holders this quarter
  • Unknown1.99M
  • Unknown616.6K
  • Unknown167.1K
  • Unknown139.9K
  • Unknown124.9K
  • Unknown121.8K
  • Unknown112.6K
  • Unknown104.0K
  • Unknown100.2K
  • Unknown99.5K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.